Safety and efficacy of pegfilgrastim administration on the same day as myelosuppressive chemotherapy (CT) in women with ovarian or primary peritoneal cancer

被引：0
|
作者：
Schuman, S. I. [1 ]
Lambrou, N. [1 ]
Robson, K. [1 ]
Gluck, S. [1 ]
Myriounis, N. [1 ]
Pearson, J. [1 ]
Alvarez, E. [1 ]
Crisp, M. P. [1 ]
Twiggs, L. B. [1 ]
Lucci, J. A. [1 ]
机构：
[1] Univ Miami, Jackson Mem Hosp, Miami, FL 33136 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
16009
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Same-Day Administration of Pegfilgrastim Following Myelosuppressive Chemotherapy: Practices and Rationale
    Darden, Christina
    Price, Mark A.
    Kaye, James A.
    Sherif, Bintu
    Marion, Sarah
    Tzivelekis, Spiros
    Garcia, Jacob
    Chandler, David
    [J]. BLOOD, 2015, 126 (23)
  • [2] Safety and efficacy of pegfilgrastim in children with cancer receiving myelosuppressive chemotherapy
    Andre, Nicolas
    El Kababri, Maria
    Bertrand, Pourroy
    Rome, Angelique
    Coze, Carole
    Gentet, Jean Claude
    Bernard, Jean Louis
    [J]. ANTI-CANCER DRUGS, 2007, 18 (03) : 277 - 281
  • [3] The safety and efficacy of day 1 versus day 2 administration of pegfilgrastim in patients receiving myelosuppressive chemotherapy for gynecologic malignancies
    Whitworth, Jenny M.
    Matthews, Kellie S.
    Shipman, Kimberly A.
    Numnum, T. Michael
    Kendrick, James E.
    Kilgore, Larry C.
    Straughn, J. Michael, Jr.
    [J]. GYNECOLOGIC ONCOLOGY, 2009, 112 (03) : 601 - 604
  • [4] The safety and efficacy of day 1 versus day 2 administration of pegfilgrastim in patients receiving myelosuppressive chemotherapy for gynecologic malignancies
    Whitworth, J.
    Matthews, K. S.
    Shipman, K.
    Numnum, T. M.
    Kendrick, J. E.
    Kilgore, L. C.
    Straughn, J. M.
    [J]. GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S31 - S31
  • [5] "Same-Day" administration of pegfilgrastim following myelosuppressive chemotherapy: clinical practice and provider rationale
    Marion, Sarah
    Tzivelekis, Spiros
    Darden, Christina
    Price, Mark A.
    Sherif, Bintu
    Garcia, Jacob
    Kaye, James A.
    Chandler, David
    [J]. SUPPORTIVE CARE IN CANCER, 2016, 24 (09) : 3889 - 3896
  • [6] “Same-Day” administration of pegfilgrastim following myelosuppressive chemotherapy: clinical practice and provider rationale
    Sarah Marion
    Spiros Tzivelekis
    Christina Darden
    Mark A. Price
    Bintu Sherif
    Jacob Garcia
    James A. Kaye
    David Chandler
    [J]. Supportive Care in Cancer, 2016, 24 : 3889 - 3896
  • [7] Safety and efficacy of pegfilgrastim in patients receiving myelosuppressive chemotherapy
    Crawford, J
    [J]. PHARMACOTHERAPY, 2003, 23 (08): : 15S - 19S
  • [8] Administration of pegfilgrastim on the same day or next day of chemotherapy
    Hoffmann, PS
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 763S - 763S
  • [9] Safety of same day administration of pegfilgrastim in breast cancer patients
    Reynolds, Kathryn
    Katz, Julia
    Nabell, Lisle
    Grant, Stefan C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] An institutional evaluation of the safety and efficacy of same-day administration of pegfilgrastim in patients receiving chemotherapy for lung cancer.
    Vraney, Jamie
    AlRawashdh, Neda
    Choi, Briana
    Abraham, Ivo
    McBride, Ali
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345